Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

India's Hilleman Laboratories to invest Rs 300 crore to develop vaccines

Thursday, October 29, 2015

Hilleman Laboratories today said it will invest around Rs 300 crore in the next 4-5 years to develop low-cost vaccines to treat diseases like cholera and meningitis.

The company is a 50:50 joint venture between MSD Pharmaceuticals and UK-based Wellcome Trust.

"We are spending around Rs 300 crore over the next 4-5 years to develop low-cost vaccines. We are developing vaccines to treat rotavirus, cholera and meningitis," Hilleman CEO Davinder Gill told PTI here.

"For research, we are looking for partners namely pharma companies, vaccine speciality companies and Government agencies to collaborate and fund the project. We had received foundational grants from MSD Pharmaceuticals and Wellcome Trust, but now we wants to be financially independent," he said.

MSD Pharmaceuticals and Wellcome Trust invested around Rs 700 crore nearly five years ago in the company which is now valued at around Rs 900 crore, he added.

MSD Pharmaceuticals (also known as Merck Sharp & Dohme or MSD in many parts of the world) is an affiliate of Merck & Co Inc.

"Normally, there is a large capital investment required for creating vaccines. We, however, have taken an approach that will allow the vaccines to be created at a lesser cost thus providing a boost to manufacturers, who can use synthetic platform technology," Gill said.

The company is developing a synthetic vaccine to fight meningitis in Asian, African and Latin American countries.

"We are developing a vaccine for rotavirus, which would be heat-resistant and easy to carry. We have already started clinical trials and it will be ready in 3-4 years," Gill said.

As per the development plan, Medicine in Need, a not- for-profit research organisation, will make available the company its formulation technology, while MSD would provide components of its existing rotavirus vaccine, he added.

 

economictimes.indiatimes.com

magazine-slider-imageMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024Nitrosamine Advance Workshop 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024